Jade Road Investments Limited
18 September 2024
JADE ROAD INVESTMENTS LIMITED
("Jade Road Investments", "JADE" or the "Company)
Update on strategic partnership with MBM Limited
Further to its announcement on 16 August 2024, Jade Road Investments Limited (AIM: JADE) is pleased to announce that it has today constituted up to £1,000,000 in principal value of convertible loan notes (CLN). The CLN is non-interest bearing, has a maturity of 10 months and is convertible at either the option of noteholders or the Company into JADE shares at a price which is 30% below the lowest closing bid price over the 30 business days prior to the date on which either party notifies the other it wishes to convert.
Jade has today issued £80,000 in principal value of CLN to MBM, having received such sum from MBM in the timeframe agreed with MBM under the terms of the two firms' strategic partnership.
Further announcements will be released to update on further tranches of the CLN being issued to MBM and others as well as updates on target investment opportunities.
The Board of JADE is excited about the prospects this partnership presents and looks forward to providing further updates in the near future.
For further information, please contact:
Jade Road Investments Limited
+44 (0) 778 531 5588
John Croft
Zeus Capital Limited - Nominated Adviser
+44 (0) 203 829 5000
James Joyce
Hybridan LLP - Nominated Broker
+44 (0) 20 3764 2341
Claire Louise Noyce
This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.